Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High – Should You Buy?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) reached a new 52-week high on Tuesday . The company traded as high as C$19.60 and last traded at C$19.43, with a volume of 34854 shares traded. The stock had previously closed at C$18.98.

Cipher Pharmaceuticals Price Performance

The company has a quick ratio of 2.67, a current ratio of 1.12 and a debt-to-equity ratio of 4.36. The firm has a market capitalization of C$491.97 million, a price-to-earnings ratio of 18.53 and a beta of 0.73. The stock’s 50 day moving average price is C$16.06 and its two-hundred day moving average price is C$15.17.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.